logo

Saudi German Hospital operates 21 additional clinics in Dammam

Zawya2 days ago
Middle East Healthcare Company (Saudi German Hospital) has commenced operating 21 additional clinics in advanced medical specialities, according to a bourse disclosure.
Located in Dammam, the expansion backs the company's strategic plan to enhance specialized services and meet the growing demand for advanced healthcare in the Eastern Province.
The new clinics are expected to have a positive impact on the company's financial and operational performance.
This will increase revenues, boost operational efficiency, and enhance patient experience, while upgrading the quality of care.
Saudi German Hospital affirmed its ongoing commitment to developing its medical services in line with the highest standards, supporting the goals of Saudi Vision 2030 to bolster healthcare services.
As of 31 March 2025, the group posted 263.93% year-on-year (YoY) higher net profits at SAR 160.13 million, compared to SAR 44 million.
All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (Syndigate.info).
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Novo Nordisk partners with Saudi Heart Association to improve cardiovascular health in Saudi Arabia
Novo Nordisk partners with Saudi Heart Association to improve cardiovascular health in Saudi Arabia

Zawya

timean hour ago

  • Zawya

Novo Nordisk partners with Saudi Heart Association to improve cardiovascular health in Saudi Arabia

Riyadh, Saudi Arabia, - Novo Nordisk, a leading global healthcare company, is excited to announce a new Memorandum of Understanding with the Saudi Heart Association (SHA), aimed at improving cardiovascular care throughout Saudi Arabia. This strategic partnership will engage clinicians in a series of educational and research initiatives designed to provide optimal, multidisciplinary care for patients across the Kingdom. The collaboration seeks to enhance patient outcomes nationwide by equipping healthcare professionals with vital knowledge and resources. This effort aligns with the objectives of Saudi Vision 2030, which aims to address the clinical and economic challenges posed by cardiovascular disease. Cardiovascular diseases present a significant public health challenge in Saudi Arabia, with rising rates of related major risk factors, including obesity, diabetes, and inflammation. Besides traditional risk factors, systemic low-grade inflammation is nowadays recognized as a driving force of atherosclerotic disease progression and plaque destabilization. In 2016, approximately 201,300 Saudi nationals were affected by cardiovascular diseases, accounting for over 45% of fatalities in the country. This partnership is dedicated to tackling these pressing issues by fostering effective management strategies and enhancing clinical practices. Novo Nordisk and SHA are committed to establishing a comprehensive framework for early intervention, significantly improving the quality of care provided to patients. The partnership will leverage diverse communication channels to reach healthcare providers, delivering thorough education on the latest advancements in cardiovascular care. "At Novo Nordisk, we understand the critical importance of collaboration in advancing cardio care," said Melvin D'Souza, General Manager at Novo Nordisk Saudi Arabia. "Our partnership with the Saudi Heart Association marks a proactive step toward enhancing cardiovascular health practices and ultimately improving patient outcomes across the Kingdom." "We are thrilled about this collaboration with Novo Nordisk and its potential impact," stated Dr. Waleed AlHabeeb, President of the Saudi Heart Association. "By working together, we can empower healthcare providers with the essential knowledge and skills to effectively manage cardiovascular patients, contributing to a healthier future for our communities." About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 76,300 people in 80 countries and markets its products in around 170 countries. For more information, visit Facebook, Instagram, X, LinkedIn and YouTube. About Saudi Heart Association Saudi Heart Association (SHA) is a professional organization dedicated to advancing the field of cardiology in Saudi Arabia. Founded in 1987, it serves as a scientific reference for local bodies and works to disseminate knowledge and best practices in cardiovascular health. SHA is involved in various activities, including research, training, and public awareness campaigns, and hosts an annual Contacts for further information Media: Julie Andersen Public Affairs Specialist LJRT@ Islam Tawfik Sr. Medical Manager IZQT@ References Tash, Adel Abdulkader and Al-Bawardy, Rasha Fahad (2023) "Cardiovascular Disease in Saudi Arabia: facts and the way forward," Journal of the Saudi Heart Association: Vol. 35: Iss. 2, Article 6. Available at:

Polio vaccination drive targets 1.3m children in government-controlled Yemen
Polio vaccination drive targets 1.3m children in government-controlled Yemen

The National

time8 hours ago

  • The National

Polio vaccination drive targets 1.3m children in government-controlled Yemen

The World Health Organisation has launched a three-day polio vaccination campaign in Yemen, targeting 1.3 million children across 12 provinces under government control. Yemen is at high risk for poliovirus outbreaks due to the civil war, which has weakened the healthcare and water hygiene systems, the WHO has said. 'With poliovirus continuing to circulate and cases confirmed in 2025, these [vaccination] campaigns are essential to interrupt transmission and protect every child from the debilitating effects of polio,' WHO Representative in Yemen Dr Ferima Coulibaly-Zerbo said. More than 280 cases of poliovirus have been recorded in Yemen since 2021, across 19 of the country's 22 provinces. Nearly all the cases have involved children under five years old. The campaign is being run by the WHO, led by the Ministry of Health, with support from Unicef – the UN agency for children - and the Global Polio Eradication Initiative. Nearly 7,000 vaccination teams, including 6,000 going door-to-door and 800 others at health care facilities, are inoculating children. 'The campaign is an important and urgent step to protect children from being paralysed by the poliovirus,' said Unicef's Representative to Yemen, Peter Hawkins. 'With confirmed cases of polio among Yemeni children, an imminent threat persists, especially for every unvaccinated child. But through vaccination we can keep our children safe.' Yemen was polio-free for decades until 2020, but national polio immunisation coverage dropped from 58 per cent in 2022 to 46 per cent in 2023, Unicef said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store